ATLANTIC PHARAMACEUTICALS INC.

Company

TG THERAPEUTICS, INC.

Filed

January 29, 1998

Accession Number

0000950128-98-000470

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →